nodes	percent_of_prediction	percent_of_DWPC	metapath
Amcinonide—ANXA1—nerve—hypothyroidism	0.0931	0.153	CbGeAlD
Amcinonide—NR3C1—urine—hypothyroidism	0.0469	0.0771	CbGeAlD
Amcinonide—ANXA1—adrenal cortex—hypothyroidism	0.0358	0.0588	CbGeAlD
Amcinonide—ANXA1—heart—hypothyroidism	0.0346	0.0569	CbGeAlD
Amcinonide—ANXA1—cardiovascular system—hypothyroidism	0.0326	0.0537	CbGeAlD
Amcinonide—NR3C1—nerve—hypothyroidism	0.0323	0.0532	CbGeAlD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—POU1F1—hypothyroidism	0.0296	0.076	CbGpPWpGaD
Amcinonide—ANXA1—gonad—hypothyroidism	0.0296	0.0487	CbGeAlD
Amcinonide—ANXA1—Prostaglandin Synthesis and Regulation—PRL—hypothyroidism	0.0295	0.0756	CbGpPWpGaD
Amcinonide—ANXA1—pituitary gland—hypothyroidism	0.0289	0.0475	CbGeAlD
Amcinonide—NR3C1—Nuclear Receptors—THRA—hypothyroidism	0.0268	0.0687	CbGpPWpGaD
Amcinonide—ANXA1—adrenal gland—hypothyroidism	0.0258	0.0425	CbGeAlD
Amcinonide—ANXA1—blood—hypothyroidism	0.0258	0.0424	CbGeAlD
Amcinonide—ANXA1—thyroid gland—hypothyroidism	0.0249	0.041	CbGeAlD
Amcinonide—ANXA1—female gonad—hypothyroidism	0.0241	0.0396	CbGeAlD
Amcinonide—ANXA1—testis—hypothyroidism	0.0213	0.0351	CbGeAlD
Amcinonide—NR3C1—Nuclear Receptor transcription pathway—THRA—hypothyroidism	0.0212	0.0543	CbGpPWpGaD
Amcinonide—ANXA1—liver—hypothyroidism	0.0202	0.0332	CbGeAlD
Amcinonide—ANXA1—cerebellum—hypothyroidism	0.0197	0.0324	CbGeAlD
Amcinonide—NR3C1—Nuclear Receptors—THRB—hypothyroidism	0.0173	0.0443	CbGpPWpGaD
Amcinonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—NKX2-1—hypothyroidism	0.0161	0.0413	CbGpPWpGaD
Amcinonide—NR3C1—Nuclear Receptor transcription pathway—THRB—hypothyroidism	0.0136	0.035	CbGpPWpGaD
Amcinonide—NR3C1—adrenal cortex—hypothyroidism	0.0124	0.0204	CbGeAlD
Amcinonide—NR3C1—heart—hypothyroidism	0.012	0.0198	CbGeAlD
Amcinonide—ANXA1—G alpha (q) signalling events—TRH—hypothyroidism	0.0116	0.0297	CbGpPWpGaD
Amcinonide—ANXA1—Peptide ligand-binding receptors—TRH—hypothyroidism	0.0114	0.0293	CbGpPWpGaD
Amcinonide—NR3C1—Endoderm Differentiation—NKX2-1—hypothyroidism	0.0114	0.0291	CbGpPWpGaD
Amcinonide—NR3C1—cardiovascular system—hypothyroidism	0.0113	0.0186	CbGeAlD
Amcinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—NKX2-5—hypothyroidism	0.0104	0.0267	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—hypothyroidism	0.0103	0.0265	CbGpPWpGaD
Amcinonide—NR3C1—gonad—hypothyroidism	0.0103	0.0169	CbGeAlD
Amcinonide—NR3C1—pituitary gland—hypothyroidism	0.01	0.0165	CbGeAlD
Amcinonide—NR3C1—adrenal gland—hypothyroidism	0.00896	0.0147	CbGeAlD
Amcinonide—NR3C1—blood—hypothyroidism	0.00896	0.0147	CbGeAlD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—DLX2—hypothyroidism	0.00865	0.0222	CbGpPWpGaD
Amcinonide—NR3C1—thyroid gland—hypothyroidism	0.00865	0.0142	CbGeAlD
Amcinonide—NR3C1—female gonad—hypothyroidism	0.00836	0.0137	CbGeAlD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.00766	0.0197	CbGpPWpGaD
Amcinonide—NR3C1—testis—hypothyroidism	0.00741	0.0122	CbGeAlD
Amcinonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—AVP—hypothyroidism	0.00702	0.018	CbGpPWpGaD
Amcinonide—NR3C1—liver—hypothyroidism	0.00701	0.0115	CbGeAlD
Amcinonide—NR3C1—cerebellum—hypothyroidism	0.00685	0.0113	CbGeAlD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.00683	0.0175	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.00683	0.0175	CbGpPWpGaD
Amcinonide—ANXA1—G alpha (q) signalling events—AVP—hypothyroidism	0.00608	0.0156	CbGpPWpGaD
Amcinonide—ANXA1—Peptide ligand-binding receptors—AVP—hypothyroidism	0.006	0.0154	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—TRH—hypothyroidism	0.00583	0.015	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—ZNF764—hypothyroidism	0.00567	0.0146	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—BGLAP—hypothyroidism	0.00565	0.0145	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—THRB—hypothyroidism	0.00558	0.0143	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—hypothyroidism	0.00543	0.0139	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—TSHR—hypothyroidism	0.0052	0.0133	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—TSHB—hypothyroidism	0.0052	0.0133	CbGpPWpGaD
Amcinonide—NR3C1—Circadian Clock—AVP—hypothyroidism	0.00511	0.0131	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—PRL—hypothyroidism	0.00417	0.0107	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.00402	0.0103	CbGpPWpGaD
Amcinonide—ANXA1—Peptide ligand-binding receptors—POMC—hypothyroidism	0.00399	0.0102	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	0.00382	0.0098	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—THRA—hypothyroidism	0.00366	0.00938	CbGpPWpGaD
Amcinonide—ANXA1—G alpha (i) signalling events—POMC—hypothyroidism	0.00336	0.00863	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—TRH—hypothyroidism	0.0033	0.00846	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—AVP—hypothyroidism	0.00306	0.00786	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—TRH—hypothyroidism	0.00299	0.00768	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—TSHR—hypothyroidism	0.00294	0.00754	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—TSHB—hypothyroidism	0.00294	0.00754	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—ZNF764—hypothyroidism	0.00273	0.00701	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.00267	0.00686	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—TSHB—hypothyroidism	0.00267	0.00684	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—TSHR—hypothyroidism	0.00267	0.00684	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—NKX2-5—hypothyroidism	0.0026	0.00668	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—POMC—hypothyroidism	0.00247	0.00633	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—THRB—hypothyroidism	0.00236	0.00604	CbGpPWpGaD
Amcinonide—Fluoxymesterone—SHBG—hypothyroidism	0.00232	1	CrCbGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.00222	0.00569	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CLTC—hypothyroidism	0.00205	0.00525	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—POMC—hypothyroidism	0.00204	0.00522	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—VAV3—hypothyroidism	0.0018	0.00461	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—TRH—hypothyroidism	0.00177	0.00454	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—THRA—hypothyroidism	0.00176	0.00452	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—AVP—hypothyroidism	0.00173	0.00444	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—IGF1—hypothyroidism	0.00164	0.00421	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—VAV3—hypothyroidism	0.00163	0.00419	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—TSHB—hypothyroidism	0.00158	0.00404	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—TSHR—hypothyroidism	0.00158	0.00404	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—AVP—hypothyroidism	0.00157	0.00403	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—SH2B3—hypothyroidism	0.0014	0.0036	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—NKX2-5—hypothyroidism	0.00125	0.00322	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—POMC—hypothyroidism	0.00115	0.00295	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—THRB—hypothyroidism	0.00113	0.00291	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—POMC—hypothyroidism	0.00104	0.00268	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PRL—hypothyroidism	0.00104	0.00267	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—VAV3—hypothyroidism	0.000964	0.00247	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—AVP—hypothyroidism	0.000929	0.00238	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—POMC—hypothyroidism	0.000617	0.00158	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—IGF1—hypothyroidism	0.000594	0.00152	CbGpPWpGaD
